|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Salles, Gilles; Schuster, Stephen J.; Fischer, Luca; Kuruvilla, John; Patten, Piers Em; Tresckow, Bastian von; Smith, Sonali M.; Ubieto, Ana Isabel Jiminez; Davis, Keith L.; Nagar, Saurabh P.; Zhang, Jie; Bollu, Vamsi; Jousseaume, Etienne; Ramos, Roberto; Wang, Yucai und Link, Brian K.
(2022):
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL).
In: Hemasphere, Bd. 6, Nr. 7, e745
Gillessen, Sarah; Pluetschow, Annette; Vucinic, Vladan; Ostermann, Helmut; Kobe, Carsten; Broeckelmann, Paul J.; Boell, Boris; Eichenauer, Dennis A.; Heger, Jan-Michel; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Engert, Andreas und Tresckow, Bastian von
(2022):
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
In: European Journal of Haematology, Bd. 109, Nr. 6: S. 728-735
Salles, Gilles; Schuster, Stephen J.; Dreyling, Martin; Fischer, Luca; Kuruvilla, John; Patten, Piers E. M.; Tresckow, Bastian von; Smith, Sonali M.; Jimenez-Ubieto, Ana; Davis, Keith L.; Anjos, Carla; Chu, Jufen; Zhang, Jie; Bodoni, Chiara Lobetti; Thieblemont, Catherine; Fowler, Nathan H.; Dickinson, Michael; Martinez-Lopez, Joaquin; Wang, Yucai und Link, Brian K.
(2022):
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.
In: Blood Advances, Bd. 6, Nr. 22: S. 5835-5843
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
Fowler, Nathan Hale; Dickinson, Michael; Dreyling, Martin; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C.; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie Jose; Andreadis, Charalambos; Riedell, Peter A.; Ho, P. Joy; Perez-Simon, Jose Antonio; Chen, Andy I.; Nastoupil, Loretta J.; Tresckow, Bastian von; Ferreri, Andres Jose Maria; Teshima, Takanori; Patten, Piers E. M.; McGuirk, Joseph P.; Petzer, Andreas L.; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Zia, Aiesha; Awasthi, Rakesh; Masood, Aisha; Anak, Oezlem; Schuster, Stephen J. und Thieblemont, Catherine
(2021):
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
In: Nature Medicine, Bd. 28, Nr. 2: S. 325-332
Broeckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Soekler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Huettmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; Tresckow, Bastian von; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter und Engert, Andreas
(2020):
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
In: Jama Oncology, Bd. 6, Nr. 6: S. 872-880